A diffusible analogue of N 3-(4-methoxyfumaroyl)-l-2,3-diaminopropanoic acid with antifungal activity-Reference-Cited by-同舟云学术

A diffusible analogue of N 3-(4-methoxyfumaroyl)-l-2,3-diaminopropanoic acid with antifungal activity

Published:2001-07-01 Issue:7 Volume:147 Page:1955-1959
ISSN:1350-0872
Container-title:Microbiology
language:en
Short-container-title:

Author:

Zgódka Dorota¹,Milewski Sławomir¹,Borowski Edward¹

Affiliation:

1. Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, 11/12 Narutowicza St, 80-952 Gdańsk, Poland1

Publisher

Microbiology Society

Subject

Microbiology

Reference19 articles.

1. Synthesis of N3-fumaramoyl-l-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase;Andruszkiewicz;Int J Pept Protein Res,1986

2. Structural determinants of inhibitory activity of N3-(4-methoxyfumaroyl)-l-2,3-diaminopropanoic acid towards glucosamine-6-phosphate synthase;Andruszkiewicz;Pol J Chem,1993

3. A new methionine antagonist that has antifungal activity: mode of action;Aoki;J Antibiot,1994

4. Novel approaches in the rational design of antifungal agents of low toxicity;Borowski;Farmaco,2000

5. Anti- Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanism of action;Capobianco;Biochem Biophys Res Commun,1993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From metabolism to disease: the biological roles of glutamine:fructose-6-phosphate amidotransferase (GFAT);Pure and Applied Chemistry;2023-08-08

2. Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics – synthesis and properties;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-07-08

3. Peptide dendrimers as antifungal agents and carriers for potential antifungal agent— N 3 ‐(4‐methoxyfumaroyl)‐( S )‐2,3‐diaminopropanoic acid—synthesis and antimicrobial activity;Journal of Peptide Science;2019-12-16

4. Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections;RSC Advances;2016